"Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine"
published Am J Transplant. 2012 Feb;12(2):289-97
Main point: "We here, in brief, introduce generation and biological importance of MVs, describe their (patho)physiological roles and their potential use as future biomarkers and therapeutic agents in transplantation medicine. Circulating MVs may have a great potential to detect possible immune rejections and MV modulation may emerge as a therapeutic approach in organ rejection therapy."